Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Careplus Group Bhd's revenue for the
three
months ended in Mar. 2026 was RM20.65 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was RM95.22 Mil.
Careplus Group Bhd's Revenue per Share for the
three
months ended in Mar. 2026 was RM0.03.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was RM0.13.
Warning Sign:
Careplus Group Bhd revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Careplus Group Bhd was -17.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -46.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -22.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 0.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Careplus Group Bhd's highest 3-Year average Revenue per Share Growth Rate was 40.90% per year. The lowest was -46.60% per year. And the median was 12.70% per year.
Careplus Group Bhd (XKLS:0163) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Careplus Group Bhd Revenue Related Terms
Careplus Group Bhd Revenue Historical Data
* Premium members only.
The historical data trend for Careplus Group Bhd's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Careplus Group Bhd's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Careplus Group Bhd Revenue vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Careplus Group Bhd's Revenue distribution charts can be found below:
* The bar in red indicates where Careplus Group Bhd's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM95.22 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Careplus Group Bhd (XKLS:0163) has a Revenue of RM95.22 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Careplus Group Bhd and its competitors.
Is Careplus Group Bhd's Revenue too high?
Careplus Group Bhd's current Revenue is RM95.22 Mil.
How does Careplus Group Bhd's Revenue compare to ISRG and BDX?
Careplus Group Bhd's Revenue of RM95.22 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Devices & Instruments company?
A good Revenue depends on the Medical Devices & Instruments industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Careplus Group Bhd and its competitors. Careplus Group Bhd's current Revenue is RM95.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Careplus Group Bhd stock overvalued right now?
Based on GuruFocus' analysis, Careplus Group Bhd (XKLS:0163) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.09, compared to a current price of RM0.08 — trading 16.7% below its estimated fair value. The current Revenue is RM95.22 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Careplus Group Bhd (XKLS:0163), the current Revenue is RM95.22 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Careplus Group Bhd is involved in the manufacturing, processing, and trading of gloves. The company's product consists of Latex exam gloves, Latex surgical gloves, and Nitrile exam gloves. Its Latex exam gloves are used in medical examinations and procedures, diagnostic procedures by the dentist, laboratory practices, and food handling practices. The Nitrile exam gloves are generally used in laboratory practices and the automotive industry. Geographically, it derives maximum revenue from Malaysia and the rest from North America, South America, Other Asia Pacific regions, and other regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0163 has been successfully added to your 
